Glaxo’s $3bn glides above the triple-B crowd
GlaxoSmithKline was the stand-out issuer in the dollar bond market this week, with a $3bn barnstormer that matched BP’s record of 0.7% for the lowest coupon on a three year Yankee bond.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts